Stomach cancer classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Stomach cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Stomach Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Endoscopy and Biopsy
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Stomach cancer classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Stomach cancer classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Stomach cancer classification
CDC on Stomach cancer classification
Stomach cancer classification in the news
Blogs on Stomach cancer classification
Directions to Hospitals Treating Stomach cancer
Risk calculators and risk factors for Stomach cancer classification

Classification

Padova classification

1. Negative for dysplasia 1.0 Normal 1.1 Reactive foveolar hyperplasia 1.2 Intestinal metaplasia (IM) 1.2.1 IM Complete type 1.2.2 IM Incomplete type

2. Indefinite for dysplasia 2.1 Foveolar hyperproliferation 2.2 Hyperproliferative IM

3. Non-invasive neoplasia (flat or elevated [synonym adenoma]) 3.1 Low-grade 3.2 High-grade 3.2.1 Including suspicious for carcinoma without invasion (intreglandular) 3.2.2 Including carcinoma without invasion (intraglandular)

4. Suspicious for invasive carcinoma

5. Invasive adenocarcinoma